FDA 510(k)

Emit II Plus Análise de Metabolito de Cocaína

Número K: K170293 · 2017-10-25

RequerenteSiemens Healthcare Diagnostics, Inc.

Data da decisão2017-10-25

Código do produtoDIO

Comité consultivoTX

DecisãoSubstantially Equivalent

Resumo do dispositivo

Emit II Plus Cocaine Metabolite Assay is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2017-10-25 under 510(k) number K170293. The device is classified under product code DIO. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the Emit II Plus Cocaine Metabolite Assay?

Emit II Plus Cocaine Metabolite Assay is a medical device that received FDA 510(k) clearance on 2017-10-25. The listed applicant is Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K170293.

When did Emit II Plus Cocaine Metabolite Assay receive FDA 510(k) clearance?

Emit II Plus Cocaine Metabolite Assay received FDA 510(k) clearance on 2017-10-25, under 510(k) number K170293.

Who is the listed applicant for Emit II Plus Cocaine Metabolite Assay?

The FDA 510(k) record lists Siemens Healthcare Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Emit II Plus Cocaine Metabolite Assay?

The FDA product code for Emit II Plus Cocaine Metabolite Assay is DIO.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Siemens Healthcare Diagnostics, Inc. como candidato(a)

K253528Atellica IM CA 19-9 II K261364Atellica CH Acetaminophen 2 (ACTM)K251998Atellica CH Diazo Total Bilirubin (D_TBil)K251543Atellica® IM TSH3-Ultra II (TSH3ULII)K251630Atellica IM Total PSA II (tPSAII)K250816ADVIA Centaur Anti-Tiroglobulina II (aTgII)

Ver todos os 64 dispositivos →

Dispositivos Relacionados (Código: DIO)

K213211Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test SystemCarolina Liquid Chemistries Corp.K211973DRI Cocaine Metabolite AssayMicrogenics Corporation K191638Pointe Scientific Cocaine Metabolite Enzyme ImmunoassayMedtest DX K181499DRI Cocaine Metabolite AssayMicrogenics Corporation K163570Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)Carolina Liquid Chemistries Corporation K162395MP DOA-10 Panel Test Cup, MP DOA-11 Panel Test CupMp Biomedicals, LLC

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.